ImmunoPrecise Antibodies Price to Book Ratio 2022-2024 | IPA
Historical price to book ratio values for ImmunoPrecise Antibodies (IPA) over the last 10 years. The current price to book ratio for ImmunoPrecise Antibodies as of November 12, 2024 is 0.53.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ImmunoPrecise Antibodies Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-12 | 0.47 | 0.53 | |
| 2024-07-31 | 0.79 | $0.88 | 0.90 |
| 2024-04-30 | 1.28 | $0.93 | 1.37 |
| 2024-01-31 | 1.81 | $1.40 | 1.29 |
| 2022-01-31 | 6.18 | $1.93 | 3.20 |
| 2021-10-31 | 6.57 | $2.09 | 3.14 |
| 2021-07-31 | 6.58 | $2.34 | 2.81 |
| 2021-04-30 | 9.76 | 0.00 | |
| 2023-01-31 | 4.40 | $1.82 | 2.42 |
| 2022-10-31 | 4.97 | $1.86 | 2.67 |
| 2022-07-31 | 4.23 | $2.07 | 2.04 |
| 2022-04-30 | 5.56 | $2.45 | 2.27 |
| 2023-10-31 | 2.30 | $1.53 | 1.51 |
| 2023-07-31 | 2.52 | $1.61 | 1.56 |
| 2023-04-30 | 2.57 | $1.74 | 1.48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.014B | $0.018B |
| ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.733B | 148.28 |
| Inspire Medical Systems (INSP) | United States | $5.716B | 178.27 |
| Axonics (AXNX) | United States | $3.603B | 1762.25 |
| IRhythm Technologies (IRTC) | United States | $2.729B | 0.00 |
| Privia Health (PRVA) | United States | $2.710B | 225.80 |
| Enovis (ENOV) | United States | $2.621B | 17.77 |
| Omnicell (OMCL) | United States | $2.264B | 74.08 |
| Azenta (AZTA) | United States | $2.250B | 112.17 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Schrodinger (SDGR) | United States | $1.620B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.617B | 0.00 |
| Phreesia (PHR) | United States | $1.235B | 0.00 |
| Standard BioTools (LAB) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.569B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.528B | 91.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.278B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.261B | 0.00 |
| TruBridge (TBRG) | United States | $0.234B | 67.96 |
| P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |